|
|
||
Metf Ch4 «SAFE ★»If carbon pricing or methane regulations are rolled back, the economic incentive for mitigation could weaken. A state-of-the-art METF CH4 system uses multi-stage configurations. For example, a two-stage system can recover >99.5% of the incoming methane while rejecting 98% of the CO₂, achieving pipeline spec (e.g., <2% CO₂, <4 ppm H₂S). metf ch4 Higher concentrations of methane generally support higher populations of methanotrophs , provided oxygen is available [1]. If carbon pricing or methane regulations are rolled ), a toxic air pollutant. High temperatures and intense sunlight accelerate the chemical reactions between CH4CH sub 4 and nitrogen oxides ( NOxNO sub x ), worsening smog and driving respiratory illness. For decades, climate policy has been dominated by For decades, climate policy has been dominated by a singular focus on carbon dioxide (CO2). CO2 is the long-lived driver of anthropogenic warming, accumulating in the atmosphere for centuries. However, this narrow focus has obscured the critical, immediate threat posed by methane (CH4). While methane is shorter-lived—persisting for roughly a decade—its global warming potential is more than 80 times greater than CO2 over a 20-year period. This potent potency means that rapid methane reductions are the single most effective lever for slowing the rate of warming in the near term, buying crucial time for deeper CO2 cuts. Yet, current carbon markets largely fail to address methane adequately. This essay argues for the creation of a dedicated , a specialized cap-and-trade system designed to account for methane’s unique properties, target its diffuse sources, and complement existing carbon markets. ________ kg Total CO2e: ________ kg GWP used: □ AR5 (28) □ AR4 (25) □ Other (___) The draft focuses on three primary pillars of documentation: |
||
|
Âñÿ ïðåäñòàâëåííàÿ íà ñàéòå èíôîðìàöèÿ, êàñàþùàÿñÿ òåõíè÷åñêèõ õàðàêòåðèñòèê, íàëè÷èÿ íà ñêëàäå, ñòîèìîñòè òîâàðîâ, íîñèò îçíàêîìèòåëüíûé õàðàêòåð è íè ïðè êàêèõ óñëîâèÿõ íå ÿâëÿåòñÿ ïóáëè÷íîé îôåðòîé, îïðåäåëÿåìîé ïîëîæåíèåì ïóíêòîì 2 ñòàòüè 437 Ãðàæäàíñêîãî êîäåêñà Ðîññèéñêîé Ôåäåðàöèè. Âñþ ïîäðîáíóþ èíôîðìàöèþ î òîâàðàõ, èõ íàëè÷èè è ñòîèìîñòè Âû ìîæåòå ïîëó÷èòü ó ìåíåäæåðîâ îòäåëà êëèåíòñêîãî ñåðâèñà. Íà äàííîì ñàéòå èñïîëüçóþòñÿ ôàéëû cookie (êóêè) â öåëÿõ ñîâåðøåíñòâîâàíèÿ ðàáîòû ñàéòà è ïîëó÷åíèÿ àíàëèòè÷åñêîé èíôîðìàöèè.  ñëó÷àå íåñîãëàñèÿ, ïðîñèì ïðîèçâåñòè ñîîòâåòñòâóþùèå íàñòðîéêè â áðàóçåðå èëè ïîêèíóòü äàííûé ñàéò. Îñòàâàÿñü íà www.art-medika.com, Âû ïðèíèìàåòå íàøó ïîëèòèêó êîíôèäåíöèàëüíîñòè. Çàïîëíÿÿ ôîðìó çàÿâêè, Âû ïîäòâåðæäàåòå ñâîå ñîãëàñèå íà îáðàáîòêó ïåðñîíàëüíûõ äàííûõ. © 2012-2019 Àðò-Ìåäèêà îáîðóäîâàíèå, ðåàãåíòû, èçäåëèÿ ìåäèöèíñêîãî íàçíà÷åíèÿ äëÿ êëèíè÷åñêîé ëàáîðàòîðíîé äèàãíîñòèêè |